Capstone Therapeutics's market cap is currently ―. The company's EPS TTM is $-31.273; its P/E ratio is -0.17; Capstone Therapeutics is scheduled to report earnings on August 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 11.04M	$ 17.71M	$ 19.51M	$ 13.31M	$ 13.78M
Gross Profit	$ 2.89M	$ 4.89M	$ 5.35M	$ 3.40M	$ 3.71M
EBIT	$ 311.00K	$ 1.69M	$ 1.94M	$ 56.00K	$ 306.00K
EBITDA	$ 324.00K	$ 1.71M	$ 2.07M	$ 130.00K	$ 490.00K
Net Income Common Stockholders	$ -476.00K	$ 544.00K	$ 850.00K	$ -928.00K	$ -295.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 23.00K	$ 197.00K	$ 262.00K	$ 236.00K	$ 50.00K
Total Assets	$ 65.21M	$ 68.99M	$ 73.34M	$ 69.18M	$ 64.07M
Total Debt	$ 28.80M	$ 31.55M	$ 28.71M	$ 31.31M	$ 28.34M
Net Debt	$ 28.78M	$ 31.36M	$ 28.45M	$ 31.07M	$ 28.29M
Total Liabilities	$ 31.88M	$ 35.18M	$ 40.88M	$ 40.29M	$ 34.99M
Stockholders Equity	$ 33.33M	$ 33.81M	$ 32.46M	$ 28.89M	$ 29.08M
Cash Flow	-
Free Cash Flow	$ 2.40M	$ -3.00M	$ 501.00K	$ -2.97M	$ 3.06M
Operating Cash Flow	$ 2.43M	$ -3.01M	$ 644.00K	$ -2.96M	$ 3.93M
Investing Cash Flow	$ -31.00K	$ 12.00K	$ -143.00K	$ -11.00K	$ -622.00K
Financing Cash Flow	$ -2.58M	$ 2.94M	$ -475.00K	$ 3.15M	$ -3.51M

Currency in USD

Capstone Therapeutics Earnings and Revenue History

Income Statement >

Capstone Therapeutics Debt to Assets

Balance Sheet >

Capstone Therapeutics Cash Flow

Cash Flow >

Capstone Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing